UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q

     |X| Quarterly Report Pursuant To Section 13 or 15(d) of The Securities
                              Exchange Act Of 1934

                  For the quarterly period ended March 31, 2012

   |_| Transition Report Under Section 13 or 15(d) of The Securities Exchange
                                   Act Of 1934

             For the transition period from __________ to __________

                       Commission File Number: 333-171658

                                NANO LABS CORP.
                          ----------------------------
             (Exact name of registrant as specified in its charter)

            Colorado                                 84-1307164
------------------------------------       ------------------------------------
 (State or other jurisdiction              (I.R.S. Employer Identification No.)
of incorporation or organization)

                                  Calle 4, #37
                     Fraccionamiento Industrial Alce Blanco
                            Municipality of Naucalpan
                       Estado de Mexico, Mexico MCP 53520
                       ----------------------------------
          (Address of principal executive offices, including Zip Code)

                               52-555-359-3446
                               ---------------
               (Issuer's telephone number, including area code)

                           Colorado Ceramic Tile, Inc.
                             4151 E. County Line Rd.
                              Centennial, CO 80122
                          ---------------------------
          (Former name or former address if changed since last report)

Check whether the issuer (1) filed all reports required to be filed by section
13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted  electronically  and
posted on its corporate Web site, if any, every  Interactive  Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of
this chapter)  during the  preceding 12 months (or for such shorter  period that
the registrant was required to submit and post such files). Yes [X] No [ ]


Indicate by check mark whether the registrant is a large  accelerated  filer, an
accelerated filer, a non-accelerated  filer, or a small reporting  company.  See
the   definitions   of   "large   accelerated   filer,"   "accelerated   filer,"
"non-accelerated  filer," and "smaller  reporting  company" in Rule 12b-2 of the
Exchange Act.

Large accelerated filer      [ ]             Accelerated filer          [ ]
Non-accelerated filer        [ ]             Smaller reporting company  [x]

Indicate by check mark whether the  registrant is a shell company (as defined in
Rule  12b-2 of the  Exchange  Act).  Yes  [ ] No [X]

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest  practicable date:  8,125,000 shares of common stock as
of April 30, 2012.


<PAGE>


                                 NANO LABS CORP.

                              FINANCIAL STATEMENTS
                                   (Unaudited)

                          Quarter Ended March 31, 2012


<PAGE>






                                 NANO LABS CORP.
                              Financial Statements


                                TABLE OF CONTENTS


                                                             Page
                                                             ----

FINANCIAL STATEMENTS

      Balance sheets                                          1
      Statements of operation                                 2
      Statements of cash flows                                3
      Notes to consolidated financial statements              5



<PAGE>



                                 NANO LABS CORP.
                                 BALANCE SHEETS
                                                              Mar. 31, 2012
                                           June 30, 2011       (Unaudited)
                                         ------------------  ----------------
   ASSETS

     Current assets
           Accounts receivable           $       21,633      $           -
           Inventory                             17,552                  -
                                         ------------------  ----------------
                  Total current assets           39,185                  -
                                         ------------------  ----------------
           Deposits                               4,193                  -
           Fixed assets - net                     4,305                  -
                                         ------------------  ----------------
     Total Assets                        $       47,683      $           -
                                         ==================  ================

   LIABILITIES & STOCKHOLDERS' EQUITY

     Current liabilities

           Bank overdraft                         1,674                  -
           Accounts payable                     243,629            230,914
           Notes payable - current              208,235             50,400
           Accrued interest payable                 318                217
                                         ------------------  ----------------
           Total current liabilities            453,856            281,531
                                         ------------------  ----------------

     Long term liabilities

           Notes payable                          5,675                  -
                                         ------------------  ----------------
           Total long term liabilities            5,675                  -
                                         ------------------  ----------------
     Total Liabilities                          459,531            281,531
                                         ------------------  ----------------
     Stockholders' Equity
           Preferred stock, $.001 par
            value; 10,000,000 shares
            authorized; No shares issued
            & outstanding                             -                  -
           Common stock, $.001 par
            value; 100,000,000 shares
            authorized; 8,125,000 shares
            issued and outstanding                8,125              8,125

           Additional paid in capital           112,499            267,794

           Accumulated deficit                 (532,472)          (557,450)
                                         ------------------  ----------------
     Total Stockholders' Equity                (411,848)          (281,531)
                                         ------------------  ----------------
     Total Liabilities and
     Stockholders' Equity                $       47,683      $           -
                                         ==================  ================



    The accompanying notes are an integral part of the financial statements.

                                       1
<PAGE>

                                         NANO LABS CORP.
                                    STATEMENTS OF OPERATIONS
                                           (Unaudited)

<TABLE>
<S>                                    <C>             <C>               <C>            <C>

                                 Three Months    Three Months      Nine Months     Nine Months
                                     Ended           Ended            Ended            Ended
                                                                                     Mar. 31,
                                 Mar. 31, 2011  Mar. 31, 2012     Mar. 31, 2011        2012
                                 -------------- ---------------  ----------------  -------------



   Sales (net of returns)        $          -   $          -     $          -      $          -
   Cost of goods sold                       -              -                -                 -
                                 -------------- ---------------  ----------------  -------------
   Gross Profit                             -              -                -                 -
                                 -------------- ---------------  ----------------  -------------
   Operating expenses:
      Depreciation                          -              -                -                 -
      General and administrative            -              -                -                 -
                                 -------------- ---------------  ----------------  -------------
                                            -              -                -                 -
                                 -------------- ---------------  ----------------  -------------
   Gain (loss) from operations              -              -                -                 -
                                 -------------- ---------------  ----------------  -------------
   Other income (expense):
        Interest expense                    -              -                -                 -
                                 -------------- ---------------  ----------------  -------------
   Income (loss) from
    continuing operations before
    provision for
    income taxes                            -              -                -                 -
   Provision for income tax                 -              -                -                 -
                                 -------------- ---------------  ----------------  -------------

   Income (loss) from
    continuing operations        $          -   $          -     $          -      $          -

   Discontinued operations:
       Income (loss) from
        discontinued
        operations (including
        loss on
        disposal of $41,590) -
        net of tax                    (42,737)       (33,395)         (135,340)         (24,978)
                                 -------------- ---------------  ----------------  -------------

   Net income (loss)             $    (42,737)  $    (33,395)    $    (135,340)    $    (24,978)
                                 ============== ===============  ================  =============

   Net income (loss) per share
   (Basic and fully diluted):
       Continuing operations                -              -                -                 -

       Discontinued operations          (0.01)         (0.00)           (0.02)            (0.00)
                                 -------------- ---------------  ----------------  -------------
       Total operations          $      (0.01)  $      (0.00)    $      (0.02)     $      (0.00)
                                 ============== ===============  ================  =============
   Weighted average number of
    common shares outstanding       8,125,000      8,125,000        6,366,667         8,125,000
                                 ============== ===============  ================  =============
</TABLE>

    The accompanying notes are an integral part of the financial statements.

                                       2
<PAGE>

                                    NANO LABS CORP.
                                STATEMENTS OF CASH FLOWS
                                      (Unaudited)


                                                Nine Months       Nine Months
                                                    Ended           Ended
                                               Mar. 31, 2011     Mar. 31, 2012
                                            -----------------  ----------------

   Cash Flows From Operating Activities:
        Net income (loss)                   $    (135,340)     $      (24,978)

        Adjustments to reconcile net
         loss to net cash provided
         by (used for) operating
         activities:
             Discontinued operations              135,340              24,978
                                            -----------------  ----------------
             Net cash provided by (used
              for) operating activities                 -                   -
                                            -----------------  ----------------

   Cash Flows From Investing Activities:
                                                        -                   -
                                            -----------------  ----------------
             Net cash provided by (used
              for) investing activities                 -                   -
                                            -----------------  ----------------

                          (Continued On Following Page)



    The accompanying notes are an integral part of the financial statements.


                                       3
<PAGE>

                                 NANO LABS CORP.
                            STATEMENTS OF CASH FLOWS
                                   (Unaudited)


                         (Continued From Previous Page)



                                                  Nine Months     Nine Months
                                                    Ended           Ended
                                               Mar. 31, 2011     Mar. 31, 2012
                                            -----------------  ----------------

   Cash Flows From Financing Activities:
                                                        -                  -
                                            -----------------  ----------------
            Net cash provided by (used for)
             financing activities                       -                  -
                                            -----------------  ----------------

   Net Increase (Decrease) In Cash                      -                  -

   Cash At The Beginning Of The Period                  -                  -
                                            -----------------  ----------------


   Cash At The End Of The Period            $           -      $           -
                                            =================  ================


   Schedule Of Non-Cash Investing And Financing Activities

   In March 2012 the Company recorded $155,295 in paid in capital from related
   party debt relief.

   Supplemental Disclosure:


   Cash paid for interest                    $          -       $          -

   Cash paid for income taxes                $          -       $          -


    The accompanying notes are an integral part of the financial statements.

                                       4
<PAGE>



                                 NANO LABS CORP.
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)


NOTE 1. ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Colorado  Ceramic Tile, Inc. (the  "Company"),  was incorporated in the State of
Colorado on March 27,  1995.  Through the end of March 2012 the Company sold and
installed stone and tile. At the end of the quarter ended March 2012 the Company
disposed of its tile  business,  by moving the related  assets into a subsidiary
corporation,  then selling that  corporation  to a former  officer for a nominal
sum.  Transferrable  liabilities  were either  moved or sold.  In April 2012 the
Company changed its name to Nano Labs Corp., and is currently evaluating various
business opportunities.

Basis of Presentation
---------------------

The accompanying unaudited financial statements have been prepared in accordance
with the instructions to Form 10-Q and do not include all of the information and
disclosures  required by generally accepted  accounting  principles for complete
financial  statements.  All adjustments which are, in the opinion of management,
necessary for a fair  presentation  of the results of operations for the interim
periods have been made and are of a recurring nature unless otherwise  disclosed
herein.  The results of operations for such interim  periods are not necessarily
indicative of operations for a full year.

Use of Estimates
----------------

The preparation of financial  statements in conformity  with generally  accepted
accounting principles requires management to make estimates and assumptions that
affect  reported  amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial  statements and the reported
amounts of revenues and expenses  during the reporting  period.  Actual  results
could differ from those estimates.

Cash and cash equivalents
-------------------------

The Company considers all highly liquid investments with an original maturity of
three months or less as cash equivalents.

Accounts receivable
-------------------

The Company reviews  accounts  receivable  periodically for  collectability  and
establishes an allowance for doubtful accounts and records bad debt expense when
deemed necessary.

Property and equipment
----------------------

Property and equipment are recorded at cost and depreciated under accelerated or
straight line methods over each item's estimated useful life.

                                       5
<PAGE>


                                 NANO LABS CORP.
                          NOTES TO FINANCIAL STATEMENTS
                                   (Unaudited)

NOTE 1. ORGANIZATION,  OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued):

Revenue recognition
-------------------

Revenue is  recognized on an accrual  basis after  services have been  performed
under contract terms,  the service price to the client is fixed or determinable,
and collectibility is reasonably assured.

Income tax
----------

The  Company  accounts  for  income  taxes  pursuant  to ASC 740.  Under ASC 740
deferred taxes are provided on a liability  method  whereby  deferred tax assets
are  recognized  for  deductible   temporary   differences  and  operating  loss
carryforwards  and deferred tax liabilities are recognized for taxable temporary
differences.  Temporary  differences  are the  differences  between the reported
amounts of assets and liabilities  and their tax bases.  Deferred tax assets are
reduced by a valuation allowance when, in the opinion of management,  it is more
likely than not that some  portion or all of the deferred tax assets will not be
realized.  Deferred tax assets and  liabilities  are adjusted for the effects of
changes in tax laws and rates on the date of enactment.

Net income (loss) per share
---------------------------

The net income (loss) per share is computed by dividing the net income (loss) by
the weighted  average number of shares of common  outstanding.  Warrants,  stock
options,  and  common  stock  issuable  upon  the  conversion  of the  Company's
preferred  stock (if any),  are not  included in the  computation  if the effect
would be  anti-dilutive  and would  increase the  earnings or decrease  loss per
share.

Financial Instruments
---------------------

The carrying value of the Company's  financial  instruments,  as reported in the
accompanying balance sheets, approximates fair value.

Long-Lived Assets
-----------------

In accordance with ASC 350, the Company  regularly reviews the carrying value of
intangible  and  other   long-lived   assets  for  the  existence  of  facts  or
circumstances,  both  internally and  externally,  that suggest  impairment.  If
impairment  testing  indicates a lack of  recoverability,  an impairment loss is
recognized by the Company if the carrying  amount of a long-lived  asset exceeds
its fair value.

                                       6
<PAGE>


Item 2. Management's  Discussion and Analysis of Financial Condition and Plan of
        Operation

     The Company's business plan involved opening additional stores in Colorado.
However, the Company has been unable to raise the additional capital required to
open additional  stores,  due to the current recession which has, in particular,
impacted the construction and home improvement sectors.

     With a view to enhancing  shareholder  value, the Company adopted a plan of
reorganization which involved:

          o    disposing of its existing business; and

          o    acquiring   another  business  that  is  not  involved  with  the
               construction or home improvement industries.

     On November 29, 2011 a reorganization plan was approved by the shareholders
that involved:

          1)   the  transfer  of all of the  Company's  assets to CCT,  Inc.,  a
               wholly-owned subsidiary of the Company;

          2)   the sale of CCT, Inc. to Sandie Venezia,  an officer and director
               of the Company for $500;

          3)   the Company's acquisition of the assets of Carbon Based Partners,
               LLC ("CBP") for $500.

     In connection with the plan of reorganization, the Company's shareholders:

          o    approved a resolution  changing the name of the Company to Carbon
               Based Partners, Inc.

          o    increased the Company's  authorized capital to 500,000,000 shares
               of common stock.

          o    approved a forward split the Company's common stock on a 36 for 1
               basis.

     As part of the  reorganization,  Sandie  Venezia and Mark  Rodenbeck,  both
officers,  directors and principal  shareholders of the Company,  agreed to each
sell 2,000,000 shares of the Company's common stock to CBP for cash.

     In November, 2011, the Company and CBP executed an Asset Purchase Agreement
and Ms.  Veneza,  Mr.  Rodenbeck  and CBP  executed a Stock  Purchase  Agreement
pursuant to the plan of  reorganization.  In December 2011 both  agreements were
mutually terminated.

                                       7
<PAGE>

     On  February  14,  2012  shareholders  owning a majority  of the  Company's
outstanding  shares  adopted  resolutions  which changed the name of the Company
back to Colorado Ceramic Tile, Inc. and reversed split the Company's outstanding
shares of common stock on a 1 for 36 basis.

     On March  28,  2012  Bernardo  Camacho  Chavarria  and Jose  Manuel  Flores
Hernandez were appointed directors of the Company.

     Following  the  appointment  of Mr.  Chavarria  and Mr.  Hernandez,  Sandie
Venezia and Mark Rodenbeck resigned as officers and directors of the Company.

     Following the resignations of Ms. Venezia and Mr. Rodenbeck,  Mr. Chavarria
and Mr. Hernandez were appointed to the positions shown below:

      Name                          Position
      ----                          --------

      Bernardo Camacho Chavarria    Chief  Executive   Officer  and  Principal
                                    Financial and Accounting Officer

      Jose Manuel Flores Hernandez  Chairman of the Board of Directors and
                                    Secretary

     Bernardo  Chavarria (age 33, August 27, 1978), for the past five years, has
been  involved  in  financing  and  providing  consulting  services  to numerous
development stage technology companies.

     Jose Hernandez (age 69,  September 22, 1942),  for the past five years, has
been  involved  in  financing  and  providing  consulting  services  to numerous
development stage technology companies.

     On March 28, 2012 Mr. Chavarria  purchased  300,000 shares of the Company's
common stock from Ms. Venezia,  and 300,000 shares of the Company's common stock
from Mr. Rodenbeck.

     On March 28, 2012 Mr. Hernandez purchased 1,700,000 shares of the Company's
common stock from Ms.  Venezia,  and 1,700,000  shares of the  Company's  common
stock from Mr. Rodenbeck.

     On March 28, 2012 Ms. Venezia purchased CCT from the Company for $500.

     On March 28, 2012 the directors and  shareholders of the Company  approved,
by written  consent,  the  following  amendments  to the  Company's  Articles of
Incorporation:

          o    an  amendment  changing  the name of the  Company  from  Colorado
               Ceramic Tile, Inc. to Nano Labs Corp.; and

                                       8
<PAGE>

          o    an  amendment  effecting a forward  stock split of the  Company's
               issued and outstanding common stock on a 25-for-1 basis.

     The name change became effective on the OTC Bulletin Board on May 7, 2012.

     The 25-for-1 forward stock split became effective on the OTC Bulletin Board
on May 10, 2012.

     As the Company is no longer  involved with the sale of tile and stone,  the
Company,  plans to become involved in the sale of proprietary industrial paints,
coatings and films manufactured with proprietary Nanotechnology.

     Using Nanotechnology,  the Company believes it can produce laminate, glass,
paints, coatings and films using less raw material and which will be thinner and
weigh significantly less than competing  products.  Construction costs are lower
for  products  using  Nanotechnology  due to the  strength,  profile  and weight
differential.  Shipping and breakage  costs are also lower due to the  product's
superior  strength.  The products which the Company plans to  manufacture  using
Nanotechnology  resist  breakage,  scratching,  pressure,  heat,  flame  and  UV
distortion better than any other products on the market today.

Item 4.  Controls and Procedures.

     (a) The Company  maintains a system of controls and procedures  designed to
ensure that  information  required to be disclosed in reports filed or submitted
under the Securities Exchange Act of 1934, as amended ("1934 Act"), is recorded,
processed,  summarized and reported,  within time periods specified in the SEC's
rules and forms and to ensure that  information  required to be disclosed by the
Company  in the  reports  that it files  or  submits  under  the  1934  Act,  is
accumulated  and  communicated  to  the  Company's  management,   including  its
Principal  Executive  and  Financial  Officer,  as  appropriate  to allow timely
decisions  regarding  required  disclosure.  As of March 31, 2012, the Company's
Principal  Executive and Financial  Officer  evaluated the  effectiveness of the
design and operation of the Company's disclosure controls and procedures.  Based
on that evaluation, the Principal Executive and Financial Officer concluded that
the Company's  disclosure  controls and procedures were effective as of December
31, 2011.

     (b) Changes in Internal  Controls.  There were no changes in the  Company's
internal control over financial  reporting during the quarter ended December 31,
2011, that materially  affected,  or are reasonably likely to materially affect,
its internal control over financial reporting.

                                     PART II
Item 6.  Exhibits

Exhibits

31.1  Certification  pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2  Certification  pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32    Certification  pursuant to Section 906 of the Sarbanes-Oxley Act.


                                       9
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.




                                       NANO LABS CORP.


May 11, 2012                           By: /s/ Bernardo Camacho Chavarria
                                           ------------------------------
                                           Bernardo Camacho Chavarria,
                                           Principal Executive, Financial and
                                           Accounting Officer
<PAGE>